Skip to content
The Policy VaultThe Policy Vault

gabapentin oral solution — CareFirst (Caremark)

Management of postherpetic neuralgia in adults

Initial criteria

  • Patient is not taking more than 3600 mg per day of gabapentin

Approval duration

12 months